Macrophage proliferation, the engine of plaque progression
Macrophage proliferation, the engine of plaque progression
批准号:
265188911
负责人:
Privatdozent Dr. Ingo Hilgendorf
金额:
$0.0万
依托单位国家:
德国
项目类别:
Independent Junior Research Groups
财政年份:
2014
资助国家:
德国
项目状态:
已结题
起止时间:
2013-12-31 至 2021-12-31
中文摘要
巨噬细胞是动脉粥样硬化病变中最丰富的细胞类型。它们摄取脂蛋白,产生炎症介质和金属蛋白酶,刺激斑块生长和不稳定。这导致心绞痛,并最终在斑块破裂和冠状动脉闭塞后发生心肌梗死。巨噬细胞在动脉粥样硬化的发病机制中起关键作用,如实验研究所证明的,其中单核细胞耗竭和单核细胞募集(病变巨噬细胞的祖细胞)的抑制减少斑块形成。这确立了斑块生长和病变巨噬细胞积聚依赖于持续的单核细胞募集和分化的流行概念。然而,申请人在最近的一项研究中挑战了这种范式,他在波士顿的博士后奖学金。它表明,随着疾病的进展,斑块巨噬细胞积累变得越来越直接依赖于局部巨噬细胞增殖,而不是单核细胞募集。这一新发现提出了许多关于斑块进展的有趣和重要的问题。所有的病变巨噬细胞都同样增殖吗?增殖的巨噬细胞对斑块炎症的特殊贡献是什么?控制病变巨噬细胞增殖的因素是什么?直接或间接抑制巨噬细胞增殖是否会减缓甚至逆转斑块的发展?巨噬细胞增殖在其他心血管疾病中的作用是什么?下面的研究方案整合了小鼠模型和人类样本分析来解决这些问题。揭示心血管疾病中巨噬细胞增殖的病理机制对于开发世界头号死亡原因急需的新治疗策略至关重要。
英文摘要
Macrophages are the most abundant cell type in atherosclerotic lesions. They ingest lipoproteins and produce inflammatory mediators and metalloproteinases that stimulate plaque growth and destabilization. This leads to angina pectoris and ultimately myocardial infarction after plaque rupture and coronary artery occlusion. Macrophages play a key role in the pathogenesis of atherosclerosis as evidenced by experimental studies in which monocyte depletion and inhibition of monocyte recruitment, the progenitor cells of lesional macrophages, reduced plaque formation. This established the prevailing concept that plaque growth and lesional macrophage accumulation depend on continuous monocyte recruitment and differentiation. The applicant challenged, however, this paradigm in a recent study from his postdoctoral fellowship in Boston. It shows that with disease progression plaque macrophage accumulation becomes increasingly and directly dependent on local macrophage proliferation rather then monocyte recruitment. This novel finding raises many interesting and important questions regarding plaque progression. Do all lesional macrophages proliferate equally? What is the particular contribution of proliferating macrophages to plaque inflammation? What are the factors that control lesional macrophage proliferation? Will direct or indirect inhibition of macrophage proliferation slow or even revert plaque development? What is the role of macrophage proliferation in other cardiovascular diseases? The following research proposal integrates mouse models and human sample analyses to address these questions. Uncovering the pathomechanisms of macrophage proliferation in cardiovascular disease is crucial for developing much needed novel therapeutic strategies for the number one cause of death in the world.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1161/circulationaha.118.033942
发表时间:
2019-02-12
期刊:
CIRCULATION
影响因子:
37.8
作者:
[Mauler, Maximilian, Herr, Nadine, Duerschmied, Daniel]
通讯作者:
Duerschmied, Daniel
c-Myb Exacerbates Atherosclerosis through Regulation of Protective IgM-Producing Antibody-Secreting Cells.
c-Myb 通过调节保护性 IgM 产生抗体分泌细胞加剧动脉粥样硬化
DOI:
10.1016/j.celrep.2019.04.090
发表时间:
2019
期刊:
Cell reports
影响因子:
8.8
作者:
[Shikatani EA, Besla R, Ensan S, Upadhye A, Khyzha N, Emoto T, Chiu F, Degousee N, Moreau JM, Perry HM, Thayaparan D, Cheng HS, Pacheco S, Smyth D, Noyan H, Zavitz CCJ, Bauer CMT, Hilgendorf I, Libby P, Swirski FK, Gommerman JL, Fish JE, Stampfli MR]
通讯作者:
Stampfli MR
Quantitative and qualitative contribution of splenic monocytes to plaque development
-
批准号:198458222
-
项目类别:Research Fellowships
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Privatdozent Dr. Ingo Hilgendorf
-
依托单位:
Innate immune cell engagement in cardiovascular disease
-
批准号:464669017
-
项目类别:Heisenberg Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Privatdozent Dr. Ingo Hilgendorf
-
依托单位:
Mechanisms by which clonal haematopoiesis of indeterminate potential (CHIP)-driver mutations confer cardiovascular risk
-
批准号:464669100
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Privatdozent Dr. Ingo Hilgendorf
-
依托单位:
国内基金
海外基金
登录
查看更多内容
BRD4通过结合TEAD1调控β细胞增殖分化的机制研究
-
批准号:82370801
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李峰
-
依托单位:
放疗通过激活GSDMD诱发细胞焦亡促进肿瘤再增殖的机制研究及干预策略探讨
-
批准号:82373299
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:程进
-
依托单位:
线粒体呼吸链复合体I对果蝇肠道干细胞增殖分化的调控作用及内在机制
-
批准号:32100586
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:陈菲
-
依托单位:
溴结构域蛋白BRD4促进三阴性乳腺癌恶性生物学行为的机制研究
-
批准号:32100584
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:卢琳琳
-
依托单位:
利用示踪新技术研究成体胰腺β细胞增殖异质性
-
批准号:32100585
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:赵欢
-
依托单位:
UBIAD1调控Ras信号的机制研究
-
批准号:32100587
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:许志亮
-
依托单位:
SAGE1通过调控TERT转录促进肿瘤细胞增殖的机制研究
-
批准号:32100582
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:葛云辉
-
依托单位:
去泛素化酶OTUD6A通过CDC6介导的细胞增殖调控机制及其致病作用
-
批准号:32070712
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:邹永新
-
依托单位:
ZDHHC6介导的AEG-1棕榈酰化修饰调控肝细胞癌发生发展的机制研究
-
批准号:32000491
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:周斌辉
-
依托单位:
蛋白去磷酸化酶1α调控激活转录因子5的稳定性及其促进神经胶质瘤细胞存活的分子机制研究
-
批准号:32070722
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:袁运生
-
依托单位: